Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2
American Journal of Cancer Research · 2024 · 14 (11) · 5269-5285
DOI: 10.62347/depw1251 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2024. Verfasst von Xianhua Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian M…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fuzhou 350001, Fujian, China.
- Department of Nuclear Medicine, The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China.
Zitieren
APA
Liu, X., & Chen, Z. (2024). Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2. American Journal of Cancer Research, 14(11), 5269-5285. https://doi.org/10.62347/depw1251
Vancouver
Liu X, Chen Z. Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2. American Journal of Cancer Research. 2024;14(11):5269-5285. doi:10.62347/depw1251
BibTeX
@article{Liu2024,
author = {Liu, Xianhua and Chen, Zhijun},
title = {Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2},
journal = {American Journal of Cancer Research},
year = {2024},
volume = {14},
number = {11},
pages = {5269--5285},
doi = {10.62347/depw1251}
}
EUVIMED